Class Action

Walgreens Lidocaine Products

Class Action

Walgreens Lidocaine Products


Case Name (Date)

Dang et al. v. Walgreens Co. d/b/a Walgreens
22-cv-177, N.D. Ill.
(Jan. 2022)


Product/Service

Walgreens pain relieving products, including patches and creams


Allegations

Misleadingly marketing products as “Maximum Strength” when other products deliver more lidocaine


Status

Pending



Class-Action Tracker

Walgreens Acne Products

Class Action

Walgreens Acne Products

Allegations: Misleadingly representing that products were safe when they contain, or were at risk of containing, the carcinogen benzene

Several Store Brand Acetaminophen Products

Class Action

Several Store Brand Acetaminophen Products

Allegations: Marketing products as safe pain relievers for pregnant women without warning consumers that scientific evidence shows prenatal exposure to APAP can cause neurodevelopmental disorders in children

Walgreens’ Infants’ Pain & Fever Acetaminophen

Class Action

Walgreens’ Infants’ Pain & Fever Acetaminophen

Allegations: Misleadingly marketing its infants’ product as specifically formulated for infants and different from its Children’s Pain & Fever Acetaminophen Oral Suspension when both medications contain the same amount and…


The Latest

Filters


Show More